Global Parkinson's Disease Therapeutics Market Set for Rapid Growth, to Reach Value Around $4.31 Bn by 2023
Zion Market Research has published a new report titled "Parkinson's Disease Therapeutics Market by Drug Class (Levodopa Combination, Dopamine Agonists, Monoamine Oxidase B (MAO-B) Inhibitors, Anticholinergic Drugs, Catechol-O-Methyltransferase (COMT) Inhibitors and Others), by Route of Administration (Oral, Transdermal, Subcutaneous, and Intestinal Infusion) and by Distribution Channel for Hospital Pharmacy, Retail Pharmacy and Online Sales: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023". According to the report, global parkinson's disease therapeutics market was valued at approximately USD 2.36 billion...
View full press release